NCT06432738View on ClinicalTrials.gov

ZL-82 Double-blind Clinical Trial

PHASE1CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

March 19, 2024

Primary Completion Date

August 15, 2024

Study Completion Date

August 15, 2024

Conditions
Healthy Person
Interventions
DRUG

ZL-82

This group of subjects take ZL-82

DRUG

ZL-82 placebo

This group of subjects take ZL-82 placebo

Trial Locations (1)

255000

Peking University Medical Shandong Hospital of Traditional Chinese Medicine, Zibo

All Listed Sponsors
lead

Chengdu Zenitar Biomedical Technology Co., Ltd

INDUSTRY

NCT06432738 - ZL-82 Double-blind Clinical Trial | Biotech Hunter | Biotech Hunter